NEW
YORK, May 16, 2024 /PRNewswire/ -- The
global pre-filled syringes market size is estimated to
grow by USD 3512.4 million from
2023-2027, according to Technavio. The market is estimated to grow
at a CAGR of almost 8.93% during the forecast period.
For more insights on the forecast market size and
historic data (2017 - 2021) - Download Free sample
report in a minutes
Forecast
period
|
2023-2027
|
Base Year
|
2022
|
Historic
Data
|
2017 - 2021
|
Segment
Covered
|
Material (Glass
pre-filled syringes and Plastic pre-filled syringes ), Type
(Disposable and Reusable ), and Geography (North America, Europe,
Asia, and Rest of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
Ajinomoto Bio Pharma
Services, ApiJect Systems Corp., AptarGroup Inc., Baxter
International Inc., Becton Dickinson and Co., Catalent Inc.,
Fresenius SE and Co. KGaA, Gerresheimer AG, Haselmeier GmbH, Nipro
Corp., Novartis AG, Owen Mumford Ltd., Recipharm AB, SCHOTT AG, SHL
Medical AG, STERINOVA, Terumo Corp., Vetter Pharma Fertigung GmbH
and Co. KG, Viatris Inc., and West Pharmaceutical Services
Inc.
|
Key Market Trends Fueling Growth
Pre-filled syringes have gained significant importance in the
pharmaceutical industry, particularly for delivering large-molecule
biologics. In 2022, 15 biologic drugs were approved by the FDA,
nine of which were available in pre-filled syringes. These syringes
offer advantages such as material and cost savings, accuracy, and
ease of administration. However, they also present challenges,
including the risk of contamination, drug wastage, and the need for
healthcare providers in emergency situations, such as anaphylactic
shock. Pre-filled syringes are commonly used for injectable
medications in chronic diseases like diabetes, multiple sclerosis,
and rheumatoid arthritis. They are also essential for home care
services and hospital pharmacies. Other applications include
insulin, mRNA COVID-19 vaccines, and saline syringes with
lubrication technology. Pre-filled syringes are subject to product
recalls and regulations, including needlestick legislations,
targeting patients and healthcare professionals.
Market Challenges
- The pre-filled syringes market confronts significant
competition from innovative drug delivery systems, including
microneedles, wearable and connected devices, and nano patches.
These non-invasive alternatives offer painless delivery, ease of
use, and controlled drug release. However, pre-filled syringes can
cause discomfort. Consequently, these advanced technologies are
poised to capture a substantial market share in the global drug
delivery sector. Chronic diseases, such as heart diseases,
diabetes, and autoimmune disorders, are major targets for these
delivery systems. Safety concerns, including needlestick injuries
and contaminated needles, fuel the demand for safer pre-filled
syringes. Biologics and biosimilars, as well as biological
therapies, are significant drug candidates for these systems. The
geriatric population and self-administering patients also benefit
from these technologies. Despite the advantages, challenges, such
as insufficient healthcare funding, medical inflation, and funding
gaps, persist, driving the search for cheaper alternatives,
including disposable syringes and oral, inhalable, and nasal drug
delivery methods. Research report provides comprehensive data
on impact of trend, driver and challenges - Buy Report
Segment Overview
This pre-filled syringes market report extensively covers market
segmentation by
- Material
- 1.1 Glass pre-filled syringes
- 1.2 Plastic pre-filled syringes
- Type
- 2.1 Disposable
- 2.2 Reusable
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Glass pre-filled syringes- The pre-filled
syringe market segmentation by material encompasses two primary
categories: glass and plastic. Glass pre-filled syringes,
considered the gold standard, offer advantages such as regulatory
ease, wider acceptability among end-users, and a larger number of
drugs available compared to plastic. These syringes are
non-reactive and stable during storage, making them ideal for
parenteral medications, especially for oxygen-sensitive drugs like
morphine. However, their oxygen permeability can be a concern. In
contrast, plastic pre-filled syringes offer benefits like API use
optimization, drug waste reduction, and convenience. They are
commonly used for self-injection devices and are preferred for
treating conditions like autoimmune disorders, rheumatoid
arthritis, cardiovascular disorders, and oncological disorders. The
annual cost burden and patient compliance are crucial factors in
treatment regimens, making self-administering devices, such as
autoinjectors and pen injectors, essential in emergency situations,
including anaphylactic shock. The market also includes vials,
conventional and disposable, for manual filling, as well as flush
syringes and safety syringes to prevent needlestick injuries. The
healthcare provider landscape involves hospital pharmacies, product
recalls, and biologics, including biosimilars and insulin. The mRNA
COVID-19 vaccine and saline syringes are essential components, with
lubrication technology and multi-chamber syringes addressing drug
waste concerns. Global healthcare costs are a significant factor,
with the market influenced by factors like drug candidates, partner
analysis, and regulatory frameworks.
For more information on market segmentation with geographical
analysis including forecast (2023-2027) and historic data (2017 -
2021) - Download a Sample Report
Research Analysis
The pre-filled syringes market encompasses the production and
distribution of syringes preloaded with medications, particularly
for managing chronic diseases such as heart diseases, autoimmune
disorders like rheumatoid arthritis, and oncological disorders.
This market is subject to various legislations, including
needlestick, ensuring patient and healthcare professional safety.
Biologics and biosimilars, including insulin and mRNA COVID-19
vaccines, are significant drug candidates for pre-filled syringes.
Assumptions about the target disease population and annual cost
burden drive the market growth. Self-injection devices, lubrication
technology, and multi-chamber syringes contribute to the market's
advancement. Conventional vials and saline syringes serve as
comparisons, while product recalls and safety concerns pose
challenges.
Market Research Overview
The Pre-filled Syringes Market encompasses the production,
distribution, and consumption of pre-filled syringes used in
various healthcare applications. These syringes come pre-loaded
with a specific dose of medication, eliminating the need for manual
dosing. The market is driven by factors such as increasing
prevalence of chronic diseases, rising demand for
self-administration of medications, and technological advancements
in syringe design. Pre-filled syringes offer benefits like improved
patient safety, reduced healthcare costs, and enhanced convenience.
The market is segmented based on syringe type, application, and end
user. The global pre-filled syringes market is expected to grow
significantly in the coming years due to the increasing focus on
patient-centric care and the need for cost-effective healthcare
solutions.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Material
-
- Glass Pre-filled Syringes
- Plastic Pre-filled Syringes
- Type
-
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pre-filled-syringes-market-size-is-set-to-grow-by-usd-3512-4-million-from-2023-2027--favorable-regulations-and-guidelines-to-boost-the-market-growth-technavio-302146435.html
SOURCE Technavio